V Verastem
| Market Cap | $494.51M |
| P/E Ratio | — |
| Forward P/E | -4.76 |
| Dividend Yield | — |
| Beta | 0.43 |
| 52W Range | $4.15 - $10.77 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Torray Funds Torray Investment Partners | 0.24% | $1.67M | 216,387 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 42 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Paterson DanPresident and CEO | Sale | 970 | $6.69 | $6.49K | 04 Feb 2026 | 05 Feb 2026 |
| Dan PatersonPresident and CEO | Sale | 970 | $6.69 | $6.49K | 04 Feb 2026 | 05 Feb 2026 |
| Calkins DanielChief Financial Officer | Sale | 5,039 | $7.16 | $36.08K | 12 Jan 2026 | 14 Jan 2026 |
| Paterson DanPresident and CEO | Sale | 10,321 | $7.16 | $73.90K | 12 Jan 2026 | 14 Jan 2026 |
| Calkins DanielChief Financial Officer | Sale | 80 | $7.86 | $628.8 | 24 Dec 2025 | 29 Dec 2025 |
| Daniel CalkinsChief Financial Officer | Sale | 80 | $7.86 | $628.8 | 24 Dec 2025 | 29 Dec 2025 |
| Stuglik Brian M | Sale | 592 | $9.14 | $5.41K | 16 Dec 2025 | 18 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 393 | $9.14 | $3.59K | 16 Dec 2025 | 18 Dec 2025 |
| Gagnon Robert E. | Sale | 283 | $9.14 | $2.59K | 16 Dec 2025 | 18 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 11 Dec 2025 | 12 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.07 | $20.14K | 10 Dec 2025 | 12 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.25 | $20.50K | 09 Dec 2025 | 09 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.50 | $21.00K | 08 Dec 2025 | 09 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.61 | $21.22K | 05 Dec 2025 | 09 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 04 Dec 2025 | 04 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 04 Dec 2025 | 04 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 03 Dec 2025 | 04 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 03 Dec 2025 | 04 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.32 | $20.64K | 02 Dec 2025 | 04 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.32 | $20.64K | 02 Dec 2025 | 04 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.39 | $20.78K | 01 Dec 2025 | 01 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.39 | $20.78K | 01 Dec 2025 | 01 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.79 | $21.58K | 28 Nov 2025 | 01 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.79 | $21.58K | 28 Nov 2025 | 01 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.32 | $20.64K | 26 Nov 2025 | 01 Dec 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.32 | $20.64K | 26 Nov 2025 | 01 Dec 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 25 Nov 2025 | 25 Nov 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 25 Nov 2025 | 25 Nov 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 24 Nov 2025 | 25 Nov 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 24 Nov 2025 | 25 Nov 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 21 Nov 2025 | 25 Nov 2025 |
| Bunn Paul A. | Sale | 6,250 | $10.00 | $62.50K | 21 Nov 2025 | 25 Nov 2025 |
| Kauffman Michael | Sale | 8,550 | $10.00 | $85.50K | 21 Nov 2025 | 25 Nov 2025 |
| Michael KauffmanDirector | Sale | 8,550 | $10.00 | $85.50K | 21 Nov 2025 | 25 Nov 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 21 Nov 2025 | 25 Nov 2025 |
| Paul A. BunnDirector | Sale | 6,250 | $10.00 | $62.50K | 21 Nov 2025 | 25 Nov 2025 |
| Paterson DanPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 03 Nov 2025 | 06 Nov 2025 |
| Paterson DanPresident and CEO | Sale | 1,299 | $9.35 | $12.15K | 03 Nov 2025 | 06 Nov 2025 |
| Dan PatersonPresident and CEO | Sale | 2,000 | $10.00 | $20.00K | 03 Nov 2025 | 06 Nov 2025 |
| Dan PatersonPresident and CEO | Sale | 1,299 | $9.35 | $12.15K | 03 Nov 2025 | 06 Nov 2025 |
| Bunn Paul A. | Sale | 8,333 | $9.06 | $75.50K | 09 Oct 2025 | 14 Oct 2025 |
| Paul A. BunnDirector | Sale | 8,333 | $9.06 | $75.50K | 09 Oct 2025 | 14 Oct 2025 |
Frequently Asked Questions
What is VSTM stock price today?
Verastem (VSTM) is currently trading at $5.63. The stock has a 52-week range of $4.15 to $10.77 and a market capitalization of $494.51M.
Is VSTM a good stock to buy in 2026?
Verastem has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -1.2%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling VSTM stock?
There have been 42 insider transactions for VSTM in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has VSTM stock performed over the past year?
Verastem (VSTM) has returned -1.2% over the past 12 months. The stock traded between $4.15 and $10.77 during this period, and is currently at $5.63.
Which hedge funds own VSTM (Verastem)?
1 tracked hedge funds currently hold VSTM in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is VSTM's market cap and valuation?
Verastem (VSTM) has a market capitalization of $494.51M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is VSTM's revenue and profitability?
Verastem reported revenue of $30.91M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.43.
What sector is VSTM in and who are its biggest institutional holders?
Verastem (VSTM) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.